Articles by M. H. Delfau-Larue
Efficiency of In Vivo Purging With Rituximab Followed by High-Dose Therapy With Autologous Peripheral Blood Stem Cell Transplantation in B-Cell Non-Hodgkin’s Lymphomas: A Single-Institution Study
ByC. Haioun,M. H. Delfau-Larue,F. Beaujean,J. L. Beaumont,K. Belhadj,C. Pautas,Y. Kirova,A. Allain,P. Gaulard,J. P. Farcet,Felix Reyes, MD High-dose therapy (HDT) with peripheral blood stem cell transplantation is a treatment option for patients with advanced follicular, marginal, and mantle cell lymphoma. In this setting, frequent contamination of peripheral blood stem cell harvests by
